Published 8 hours ago • loading... • Updated 8 hours ago

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

Weight regain is common after stopping GLP-1 medications like Ozempic and Mounjaro. Nutritionist Kim Pearson shares habits that help maintain results.

1 Articles

Women's Health

Lean Left

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

Weight regain is common after stopping GLP-1 medications like Ozempic and Mounjaro. Nutritionist Kim Pearson shares habits that help maintain results.

8 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated7 hours agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Women's Health broke the news 8 hours ago on Sunday, October 18, 2026.

Sources are mostly out of (0)

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

1 Articles

1 Articles

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

CHMP Endorses Eli Lilly’s GLP-1 Pill and Three Other New Drugs

Ozempic Drugs Can Cause Nails to Loosen, New Study Shows

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery

These Are the 10 Companies that Pay the Most with the Protein Boom in Spain

Eli Lilly’s Weight-Loss Pill Wins Backing in Europe

Spain Announces a Regulation to Regulate How Kefir Is Produced and What Should Explain Packaging Labels

Similar News Topics

Similar News Topics

More stories like this

CHMP Endorses Eli Lilly’s GLP-1 Pill and Three Other New Drugs

Ozempic Drugs Can Cause Nails to Loosen, New Study Shows

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery

These Are the 10 Companies that Pay the Most with the Protein Boom in Spain

Eli Lilly’s Weight-Loss Pill Wins Backing in Europe

Spain Announces a Regulation to Regulate How Kefir Is Produced and What Should Explain Packaging Labels

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

1 Articles

1 Articles

Research Shows Weight Regain Is Common After Stopping GLP-1s. A Nutritionist Shares What Actually Helps

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

CHMP Endorses Eli Lilly’s GLP-1 Pill and Three Other New Drugs

Ozempic Drugs Can Cause Nails to Loosen, New Study Shows

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery

These Are the 10 Companies that Pay the Most with the Protein Boom in Spain

Eli Lilly’s Weight-Loss Pill Wins Backing in Europe

Spain Announces a Regulation to Regulate How Kefir Is Produced and What Should Explain Packaging Labels

Similar News Topics

Similar News Topics

More stories like this

CHMP Endorses Eli Lilly’s GLP-1 Pill and Three Other New Drugs

Ozempic Drugs Can Cause Nails to Loosen, New Study Shows

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery

These Are the 10 Companies that Pay the Most with the Protein Boom in Spain

Eli Lilly’s Weight-Loss Pill Wins Backing in Europe

Spain Announces a Regulation to Regulate How Kefir Is Produced and What Should Explain Packaging Labels

Bias Distribution

Factuality